Pemigatinib

ATC L01EN02 · 9 markets · 29 records

Pemigatinib 9 markets · 29 records Forms

US 6 records · 3 strengths

13.5 mgtabletPEMAZYRE+1Manufacturer: Lonza Tampa LLC also in AU·GB·CA +3
9 mgtabletPEMAZYRE+1Manufacturer: Lonza Tampa LLC also in AU·GB·CA +3
4.5 mgtabletPEMAZYRE+1Manufacturer: Lonza Tampa LLC also in AU·GB·CA +3

AU 4 records · 4 strengths

13.5 mgtabletPEMAZYRE pemigatinib 9 mg tablet blister pack also in US·GB·CA +3 unknown
9 mgtabletPEMAZYRE pemigatinib 9 mg tablet blister pack also in US·GB·CA +3 unknown
4.5 mgtabletPEMAZYRE pemigatinib 9 mg tablet blister pack also in US·GB·CA +3 unknown

Records without a stated strength · 1 PEMAZYRE

GB 3 records · 3 strengths

13.5 mgtabletPEMAZYRE also in US·AU·CA +3
9 mgtabletPEMAZYRE also in US·AU·CA +3
4.5 mgtabletPEMAZYRE also in US·AU·CA +3

CA 3 records · 3 strengths

13.5 mgtabletPEMAZYRE also in US·AU·GB +3
9 mgtabletPEMAZYRE also in US·AU·GB +3
4.5 mgtabletPEMAZYRE also in US·AU·GB +3

SG 3 records · 3 strengths

13.5 mgtabletPEMAZYRE also in US·AU·GB +3
9 mgtabletPEMAZYRE also in US·AU·GB +3
4.5 mgtabletPEMAZYRE also in US·AU·GB +3

ES 3 records · 3 strengths

13.5 mgtabletPEMAZYRE also in US·AU·GB +3
9 mgtabletPEMAZYRE also in US·AU·GB +3
4.5 mgtabletPEMAZYRE also in US·AU·GB +3

TW 3 records · 3 strengths

13.5 mgtabletPEMAZYRE+1達伯坦錠13.5毫克 also in US·AU·GB +3
9 mgtabletPEMAZYRE+1達伯坦錠9毫克 also in US·AU·GB +3
4.5 mgtabletPEMAZYRE+1達伯坦錠4.5毫克 also in US·AU·GB +3

HK 3 records · 1 strengths

Records without a stated strength · 1 PEMAZYRE

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 PEMAZYRE

Side-by-side table

Strength / form / release	US	GB	CA	AU	SG	ES	TW	HK	EU
13.5 mg tablet	Manufacturer: Lonza Tampa LLC ×3 PEMAZYRE	PEMAZYRE	PEMAZYRE	PEMAZYRE pemigatinib 9 mg tablet blister pack	PEMAZYRE	PEMAZYRE	PEMAZYRE 達伯坦錠13.5毫克	not recorded	not recorded
9 mg tablet	Manufacturer: Lonza Tampa LLC ×3 PEMAZYRE	PEMAZYRE	PEMAZYRE	PEMAZYRE pemigatinib 9 mg tablet blister pack	PEMAZYRE	PEMAZYRE	PEMAZYRE 達伯坦錠9毫克	not recorded	not recorded
4.5 mg tablet	Manufacturer: Lonza Tampa LLC ×3 PEMAZYRE	PEMAZYRE	PEMAZYRE	PEMAZYRE pemigatinib 9 mg tablet blister pack	PEMAZYRE	PEMAZYRE	PEMAZYRE 達伯坦錠4.5毫克	not recorded	not recorded
not disclosed unknown	not recorded	not recorded	not recorded	PEMAZYRE	not recorded	not recorded	not recorded	PEMAZYRE	PEMAZYRE

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.